Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer

BACKGROUND Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. Kallikrein 4 (KLK4/hK4) is expressed in both PCa and mineralized tissues. We determined if KLK4/hK4 expression was associated with, and influenced by, the bone environment of metastatic PCa. METHODS Imm...

Full description

Saved in:
Bibliographic Details
Published inThe Prostate Vol. 67; no. 4; pp. 348 - 360
Main Authors Gao, Jin, Collard, Rachael L., Bui, Loan, Herington, Adrian C., Nicol, David L., Clements, Judith A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.03.2007
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. Kallikrein 4 (KLK4/hK4) is expressed in both PCa and mineralized tissues. We determined if KLK4/hK4 expression was associated with, and influenced by, the bone environment of metastatic PCa. METHODS Immunohistochemistry, in vitro co‐culture, cell migration, and attachment assays. RESULTS hK4 was localized to tumor cells and osteoblasts in bone metastases. KLK4/hK4 increased in LNCaP and PC3 cells co‐cultured with SaOs2 cells; SaOs2 KLK4/hK4 was unchanged. Co‐culture did not affect cell proliferation but altered alkaline phosphatase activity/mRNA levels in SaOs2 cells. KLK4‐transfected PC3 cells had increased migration towards SaOs2 conditioned medium and greater attachment to the bone‐matrix proteins, collagens I and IV. CONCLUSIONS hK4 expression and interaction with both tumor cells and osteoblasts suggests a role for hK4 in PCa bone metastasis. Whether this observation is unique to bone metastasis or reflects a role for hK4 in PCa metastasis generally is yet to be established. Prostate 67: 348–360, 2007. © 2007 Wiley‐Liss, Inc.
Bibliography:National Health and Medical Research Council (NHMRC) of Australia - No. 101202
Queensland Cancer Foundation
ArticleID:PROS20465
NHMRC Peter Doherty Post-doctoral Fellowship
istex:9A6ABA2CE7C0302DE614DBD63C564A8561DE729B
ark:/67375/WNG-1M7BB1WN-P
Queensland Cancer Fund PhD Scholarship
Jin Gao and Rachael L. Collard contributed equally to the work as first authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0270-4137
1097-0045
DOI:10.1002/pros.20465